EDAP TMS reported EUR10.38M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.





Selling And Administration Expenses Change Date
AngioDynamics USD 35.99M 14K Feb/2025
Boston Scientific USD 1.83B 93M Dec/2025
EDAP TMS EUR 10.38M 1.15M Jun/2025
Henry Schein USD 760M 17M Sep/2025
Medtronic 2.97B 159M Sep/2025
Veracyte USD 51.73M 5.91M Sep/2025